GAM Systematic’s Bristol-Myers Squibb BMY Stock Holding History

GAM Systematic’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.39M	Buy	21,744 +2,900	+15%	+$169K	0.2%	193
2017 Q2	$1.05M	Buy	+18,844	New	+$1.03M	0.15%	271
2016 Q1	–	Sell	-3,758	Closed	-$259K	–	627
2015 Q4	$259K	Sell	3,758 -4,110	-52%	-$272K	0.07%	416
2015 Q3	$466K	Sell	7,868 -13,237	-63%	-$840K	0.11%	358
2015 Q2	$1.4M	Sell	21,105 -8,642	-29%	-$570K	0.18%	212
2015 Q1	$1.92M	Buy	29,747 +25,723	+639%	+$1.61M	0.26%	170
2014 Q4	$238K	Buy	+4,024	New	+$227K	0.05%	325

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GAM Systematic's BMY Position: Q3 2017 in Review

GAM Systematic increased its Bristol-Myers Squibb (BMY) stake by 15% in Q3 2017, buying an estimated $169K and bringing the position to 21,744 shares worth $1.39M. The position accounts for 0.2% of the portfolio, ranked #193.

GAM Systematic first reported a position in BMY in Q4 2014 and has held it in 7 quarters since. The position peaked at $1.92M in Q1 2015. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

GAM Systematic held 21,744 shares of Bristol-Myers Squibb worth $1.39M as of Q3 2017.
GAM Systematic bought 2,900 Bristol-Myers Squibb shares in Q3 2017, an estimated $169K.
Bristol-Myers Squibb made up 0.2% of GAM Systematic's portfolio in Q3 2017, its #193 holding.
GAM Systematic first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 7 quarters since.
GAM Systematic's Bristol-Myers Squibb position peaked at $1.92M in Q1 2015.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.